Cancer drugs even if they work there is too much redtape to get through to show it as a "cure" for cancer. It's a different market hence they focus on margins rather than wholesale market. ILA isn't playing in that market. We have a drug that previously went through approvals but didn't work for what it was being researched for. It's being re-purposed as it has hopes for being effective for the current target. I have good hopes for this imho. But yes biotechs are binary plays it works or it doesn't. Let's see what the next 12 month brings to investors.
ILA Price at posting:
19.5¢ Sentiment: None Disclosure: Held
